We employed the CRISPR/Cas9 genome editing platform for the generation of the desired targeted genomic rearrangement in the A549 lung cancer cell line. Single guide RNAs (sgRNAs) designed and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback